Halozyme Therapeutics HALO Q1 2026 Earnings EPS Beat Highlights Strong Operational Execution NMFC Q1 2026 Earnings EPS Misses Estimate by a Narrow Margin Stock Unchanged DocGo Q1 2026 Earnings EPS Misses Estimates but Shares Rise FibroBiologics FBLG Q1 2026 Earnings Narrow EPS Miss as PreRevenue Biotech Continues RD Investment Sunoco LP SUN Q1 2026 Earnings Massive EPS Beat Highlights Operational Strength LBTYK Q1 2026 Earnings Massive EPS Surprise Overshadows Revenue Ambiguity